Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.

Kazuya Takeda,Yoshihide Kawasaki,Toru Sakayauchi,Chiaki Takahashi,Yu Katagiri,Takaya Tanabe,Yojiro Ishikawa,Keisuke Fujimoto,Masaki Kubozono, Maiko Kozumi,Keiko Abe,Kakutaro Narazaki,Shun Tasaka,Rei Umezawa,Takaya Yamamoto,Noriyoshi Takahashi,Yu Suzuki,Keita Kishida,So Omata, Akihiro Ito,Keiichi Jingu

Asia Oceania journal of nuclear medicine & biology（2023）

引用 0|浏览8

暂无评分

摘要

Accomplishing six courses of Ra-223 treatment without grade 3 or higher acute adverse events was a prognostic factor in patients with mCRPC treated with Ra-223. We built a predictive score of treatment success and need future external validation.

查看译文

关键词

Bone metastasis,Castration-resistant prostate cancer,Radioisotope therapy,Radium-223 dichloride

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要